Daniel D Burgess's Net Worth

$511 Thousand

Estimate Recalculated Apr 1, 2025 09:49PM EST

Who is Daniel D Burgess

Daniel D Burgess does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nabriva Therapeutics Plc, Arbutus Biopharma Corp, Nabriva Therapeutics plc, Cidara Therapeutics, Inc., SANTARUS INC, METABASIS THERAPEUTICS INC, and HOLLIS EDEN PHARMACEUTICALS INC /DE/.

SEC CIK

Daniel D Burgess's CIK is 0001239650

Past Insider Trading and Trends

2013 was Daniel D Burgess's most active year for acquiring shares with 7 total transactions. Daniel D Burgess's most active month to acquire stocks was the month of May. 2013 was Daniel D Burgess's most active year for disposing of shares, totalling 11 transactions. Daniel D Burgess's most active month to dispose stocks was the month of December. 2018 saw Daniel D Burgess paying a total of $99,000.00 for 113,000 shares, this is the most they've acquired in one year. In 2014 Daniel D Burgess cashed out on 378,000 shares for a total of $9,712,840.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Nabriva Therapeutics Plc

Investor
Updated Jun 27, 2017
Form 4
30.30K
Jun 27, 2017
10.10K
Acq/Dis
Jun 23
Showing 1 results

Arbutus Biopharma Corp

Investor
Updated May 24, 2024
Form 4
67.00K
May 24, 2024
67.00K
Grant
May 23
Form 4
55.00K
May 26, 2023
55.00K
Grant
May 24
Form 4
41.00K
May 26, 2022
41.00K
Grant
May 25
Form 4
22.00K
Jun 07, 2021
22.00K
Grant
Jun 03
Form 4
22.00K
Jun 01, 2020
22.00K
Grant
May 28
Form 4
22.00K
Aug 20, 2019
22.00K
Grant
Aug 17
Form 4
22.00K
Jun 22, 2018
22.00K
Grant
Jun 19
Form 4
22.00K
Jun 22, 2017
22.00K
Grant
Jun 21
Form 4
50.00K
Mar 27, 2017
50.00K
Grant
Mar 24
Form 3
Mar 27, 2017
Showing 10 results

Nabriva Therapeutics plc

Investor
Updated Aug 04, 2022
Form 4
-52.20%
-11.34K
$0.19
-$2.16K
Aug 04, 2022
10.38K
Sale
Aug 02
Form 4
-4.92%
-1.13K
$1.20
-$1.35K
Aug 04, 2021
21.73K
Sale
Aug 02
Form 4
981.31%
52.50K
Jul 30, 2021
57.85K
Grant
Jul 28
Form 4
145.83%
52.50K
Jul 31, 2020
88.50K
Grant
Jul 29
Form 4
35.00K
Aug 01, 2019
35.00K
Grant
Jul 31
Form 4
51.00K
$2.75
$99.00K
Aug 02, 2018
51.00K
Purchase
Jul 31 - Aug 01
Form 4
29.00K
May 04, 2018
29.00K
Grant
May 02
Form 4
10.10K
Sep 19, 2017
10.10K
Grant
Sep 15
Form 3
Dec 30, 2016
Showing 9 results

Cidara Therapeutics, Inc.

Investor
Updated Jul 19, 2024
Form 4
2.13K
Jul 19, 2024
2.13K
Grant
Jul 18
Form 4
42.50K
Jun 23, 2023
42.50K
Grant
Jun 22
Form 4
28.00K
Jun 24, 2022
28.00K
Grant
Jun 22
Form 4
17.50K
Jun 24, 2021
17.50K
Grant
Jun 23
Form 4
17.50K
Jun 25, 2020
17.50K
Grant
Jun 25
Form 4
11.00K
Jun 27, 2019
11.00K
Grant
Jun 17
Form 4
11.00K
Jun 15, 2018
11.00K
Grant
Jun 13
Form 4
11.00K
Jun 23, 2017
11.00K
Grant
Jun 22
Form 4
9.00K
Jun 24, 2016
9.00K
Grant
Jun 22
Form 4
9.00K
Jun 11, 2015
9.00K
Grant
Jun 09
Form 4
3.00K
$16.00
$48.00K
Apr 21, 2015
3.00K
Purchase
Apr 20
Form 3
Apr 14, 2015
Showing 12 results

SANTARUS INC

Investor
Updated Jan 06, 2014
Form 4
-100.00%
-378.00K
$26.07
-$9.71M
Jan 06, 2014
Disposition
Jan 02
Form 4
37.00K
Jun 12, 2013
37.00K
Grant
Jun 11
Form 4
-100.00%
-8.00K
$12.17
-$146.73K
Jun 04, 2013
Sale
ScheduledJun 03
Form 4
-50.00%
-8.00K
$10.44
-$119.05K
May 02, 2013
8.00K
Sale
ScheduledMay 01
Form 4
-22.22%
-8.00K
$9.78
-$123.05K
Apr 02, 2013
28.00K
Sale
ScheduledApr 01
Form 4
-33.33%
-8.00K
$7.28
-$97.51K
Mar 04, 2013
16.00K
Sale
ScheduledMar 01
Form 4
-25.00%
-8.00K
$7.23
-$96.80K
Feb 04, 2013
24.00K
Sale
ScheduledFeb 01
Form 4
37.00K
Jun 14, 2012
37.00K
Grant
Jun 13
Form 4
37.00K
Jun 16, 2011
37.00K
Grant
Jun 15
Form 4
32.00K
Mar 11, 2011
32.00K
Grant
Mar 10
Form 4
37.00K
Jun 11, 2010
37.00K
Grant
Jun 10
Form 4
37.00K
Jun 12, 2009
37.00K
Grant
Jun 11
Form 4
32.00K
Mar 17, 2009
32.00K
Grant
Mar 16
Form 4
37.00K
Jun 16, 2008
37.00K
Grant
Jun 12
Form 4
37.00K
Jun 15, 2007
37.00K
Grant
Jun 14
Form 4
35.00K
Jun 09, 2006
35.00K
Grant
Jun 07
Form 4
20.00K
Jun 10, 2005
20.00K
Grant
Jun 09
Form 4/A
40.00K
Sep 22, 2004
40.00K
Grant
Jul 27
Form 4
Jul 28, 2004
40.00K
Form 3
Jul 28, 2004
Showing 20 results

METABASIS THERAPEUTICS INC

Investor
Updated Jun 24, 2009
Form 4
10.00K
Jun 24, 2009
10.00K
Grant
Jun 23
Form 4
10.00K
Jun 11, 2008
10.00K
Grant
Jun 10
Form 4
10.00K
Jun 05, 2007
10.00K
Grant
Jun 01
Form 4
10.00K
May 11, 2006
10.00K
Grant
May 09
Form 4
10.00K
May 19, 2005
10.00K
Grant
May 18
Form 4
13.42K
Jul 30, 2004
13.42K
Grant
Jun 21
Form 3
Jun 15, 2004
Form 3
Jun 15, 2004
Showing 8 results

HOLLIS EDEN PHARMACEUTICALS INC /DE/

COO/CFO
Updated Feb 15, 2007
Form 4
-15.56%
-2.25K
$5.50
-$12.38K
Feb 15, 2007
12.21K
Sale
ScheduledFeb 14
Form 4
50.00K
Dec 13, 2006
50.00K
Grant
Dec 11
Form 4
845.86%
36.00K
Feb 15, 2006
40.26K
Grant
Feb 13
Form 4
39.00K
Feb 15, 2005
39.00K
Grant
Feb 11
Form 4
50.00K
Jan 21, 2004
50.00K
Grant
Jan 16
Showing 5 results